Helicobacter pylori (H pylori) infection plays a significant role in peptic ulcer disease, which is a major cause of upper gastrointestinal (GI) bleeding. 1, 2 Despite the introduction of H pylori eradication therapy, the rates of peptic ulcer-related complications such as bleeding and perforation have remained high. 3 The cause of peptic ulcer bleeding has been correlated to exposure to drugs, especially non-steroidal anti-inflammatory drugs (NSAID). 4, 5 Although the selective cyclooxygenase-2 (COX-2) NSAIDs have less gastrointestinal toxicity, both selective and nonselective COX-2 NSAIDs have been shown to induce peptic ulcerrelated complications. 6−9 Since NSAIDs are usually prescribed for aged subjects with arthritis, NSAIDsrelated peptic ulcer disease becomes a vital issue in the elderly. 10 In the past, both H pylori infection and peptic ulcer disease were prevalent in Taiwan. 11 However, recent studies indicate the prevalence of H pylori infection and complications of peptic ulcer disease have been significantly reduced. 12 Although Taiwan has been a geriatric country since 1993, 13 and the consumption of NSAIDs and low dose aspirin have increased progressively in the recent decade, the role of H pylori infection and exposure to drugs such as NSAIDs and aspirin as the causes of peptic ulcer bleeding in Taiwan is undetermined. Additionally, the clinical outcome of peptic ulcer bleeding due to different etiologies has not been investigated. More recently, the H pylori negative and drug negative group has raised the attention of researchers because of its characteristic clinical course and outcome. 14−16 The aim of this study is to determine the cause, endoscopic features, and outcome of peptic ulcer bleeding related to different etiologies in a community hospital in southern Taiwan.
Materials and Methods

Patients
This prospective study was conducted in consecutive patients who presented to the Emergency Department (ED) of E-Da University Hospital with tarry stool or hematemesis from July 1, 2007 to June 31, 2008. E-Da hospital a 1000 bed community hospital located in Kaohsiung County in southern Taiwan, with a population of approximately 1,200,000. Most of the inhabitants are elderly farmers and housewives. The hospital ED receives approximately 200 outpatients daily.
Patients received emergent esophagogastroduodenoscopy (EGD) within 24 hours after arrival at the ED. Patients with actively bleeding ulcers, or ulcers with stigmata of recent hemorrhage on EGD evaluation were enrolled. The exclusion criteria were (1) bleeding from esophageal or gastric varices; (2) Mallory-Weiss tear; (3) upper gastrointestinal malignancy; (4) chronic diseases with bleeding tendency; and (5) age < 18 years.
The baseline demographic characteristics were collected by structured interview and included age, gender, clinical history, alcohol use, smoking, and medication history. The drugs related to peptic ulcer bleeding surveyed included non-selective NSAIDs, selective COX-2 NSAIDs, warfarin, aspirin, clopidogrel, and other drugs with potential risks of peptic ulcer bleeding. The patients who received drug treatment within the recent 3 months before peptic ulcer bleeding were defined as positive exposure. The amount of blood transfused, rebleeding events, and days of hospitalization were also recorded. This study was approved by the Institutional Review Board of E-Da Hospital and I-Shou University (IRB number: E-MRP-096-0019).
Endoscopic evaluation and H pylori determination
EGD was performed by experienced endoscopists using the Olympus Q260 endoscope (Tokyo, Japan). If actively bleeding ulcers or ulcers with stigmata of recent hemorrhage were noted by EGD, therapeutic endoscopy was considered. After hemostasis, endoscopic biopsy from the non-ulcer areas of the antrum was performed for the biopsy urease test and histological examination for evidence of H pylori infection. The biopsied specimens were fixed in formalin, mounted, cut, and then stained with hematoxylin and eosin for histological examination. Giemsa stain was used to identify H pylori. If discordant results were noted, the C-13 urease breath test (Helico-BT "K.M.") was further used to evaluate the status of H pylori infection. H pylori infection was considered present if two or all of the three tests (biopsy urease test, histological examination, C-13 urease breath test) were positive. The absence of H pylori infection was defined as two of the three tests having negative results.
Statistical analysis
All subjects could be classified into four groups according to drug exposure and H pylori status. These groups were: H pylori infection only, drug exposure only, combined H pylori infection and drug exposure, neither H pylori infection or drug exposure. The general linear model was applied to compare the differences among the four groups. A multiple linear regression model was utilized to analyze the relationship between clinical outcome and associated factors. A logistic regression model was used to test the odds ratio (OR) of various risk factors to different types of peptic ulcer. Statistical analyses were conducted by using SAS, version 9.1 (SAS Institute, Cary, NC, USA). A p value < 0.05 was considered statistically significant. Table 1 ). However, GU only was more frequently noted in patients with drug exposure (p < 0.05; Table 1 ). Endoscopic therapy was administered to 50 patients (24.5%). Patients with neither H pylori infection or drug exposure had a higher rate of receiving endoscopic therapy (40%) than patients with both drug exposure and H pylori infection (16.4%; p = 0.04; Table 3 ).
Results
Demographic characteristics
Outcome analysis
A total of 87 patients (42.6%) received a blood transfusion due to acute upper GI bleeding with a mean transfusion volume of packed red blood cells (RBCs) of 1.1 ± 1.5 U (Table 3 ). There was no significant difference in the amount of blood transfused in the four groups ( Table 3 ). The mean duration of hospitalization was 5.7 ± 4.0 days, and the overall rebleeding rate was 4.0%. One 77-yearold male patient who was receiving warfarin therapy for prevention of vascular thrombosis died of bleeding with complications. After adjusting all confounding factors, including age, gender, comorbidities, smoking, alcohol use, drug usage, H pylori 
Discussion
H pylori infection and drug exposure are two major causes of upper gastrointestinal bleeding. 1, 2, 4, 5 After the introduction of H pylori eradication therapy to prevent ulcers and bleeding, the primary cause of peptic ulcer bleeding has become drug exposure, especially NSAIDs, in Western countries. 17 H pylori infection was common in Taiwan, with a high prevalence of 54.4%. 11 However, after the introduction of H pylori eradication, peptic ulcer related events such as bleeding and perforation have decreased dramatically. 12 By contrast, Taiwan has become a geriatric country, with 10.4% of population over 65 years of age in 2008. 13 NSAIDs commonly used for pain relief in the elderly have become one of the major causes of peptic ulcer bleeding. 18 The mean age of patients with peptic ulcer bleeding in this study was 64.8 years, reflecting a vulnerable population with frequent NSAID exposure. Thus, more NSAID related ulcer bleeding would be anticipated in Taiwan, and the major etiology of peptic ulcer bleeding might shift from H pylori infection to NSAID usage in the future.
In this study, 52.5% of patients with peptic ulcer bleeding had a history of drug exposure (Table 1 ). This indicates that drug exposure, rather than H pylori infection, has become an important cause of peptic ulcer bleeding in Taiwan. The changing trend is likely related to an older population with more frequent drug exposure, an overall improvement of the socioeconomic status, and wide use of eradication therapy resulting in reduction of H pylori infection in Taiwan. 12 Although drugs for relieving pain due to osteoarthritis or rheumatic arthritis are considered to be the leading causes of peptic ulcer bleeding in this study, direct evidence is still lacking because two-thirds of the patients with peptic ulcer bleeding and history of drug exposure could not accurately identify the names and compositions of the drugs they used. In Taiwan, people may take over-the-counter analgesics, antipyretics, NSAIDs, and Chinese herbs for relieving symptoms of arthralgia, myofacial pain, upper respiratory tract infection, and gout, instead of using prescriptions from physicians. Thus, it is very difficult to determine a complete history of drug exposure. Therefore, more education regarding drug safety should be provided from the physicians and government in this aged population to prevent recurrent bleeding.
In our study, we found 25 definite users of NSAIDs, including ketorolac, diclofenac, ibuprofen, indomethacin and celecoxib, and 44 users of drugs for arthralgia that were likely to be NSAIDs; thus, 61.7% (69 of 107) of patients may have druginduced ulcer bleeding related to NSAIDs. Our study confirmed that even selective COX-2 inhibitors such as celecoxib can cause ulcer bleeding. 6−9 However, non-selective COX-2 inhibitors tend to have a shorter latent period to bleeding in contrast to celecoxib. This result is consistent with previous studies. 19, 20 Whether this phenomenon is related to genetic variation, such as polymorphism of the CPY2C9 gene, 21 requires further investigation.
Aspirin, clopidogrel, and warfarin can also induce ulcer bleeding. Aspirin used by patients in this study was for the prevention of coronary artery disease, therefore a low dose (100 mg) was used, with a median exposure time of 90 days. This result is consistent with a previous study by Lanas et al. 6 Clopidogrel is increasingly used in patients with coronary artery diseases with or without stent therapy. The side effect of antiplatelet reactivity may be peptic ulcer bleeding. 22 In this study, the ulcer bleeding in seven patients was related to clopidogrel, and the exposure time was long (median exposure time, 90 days). Drugs used in the treatment of upper airway infection and gout in this study were likely to be antipyretics, antibiotics, colchicine, and allopurinol, however, this requires further confirmation.
The H pylori negative and drug negative group accounted for 17.2% of the patients in this study. This group required a greater number of therapeutic endoscopies than the other groups. The duration of hospitalization for this group of patients also tended to be longer and rebleeding rate tended to be higher ( Table 3 ). The reason for the relatively poor outcome of this group might be a higher number of comorbidities in these patients ( Table 1 ). These results are consistent with previous studies. 16 Reconfirmation of the results of H pylori testing, clarification of medical history, exclusion of neoplasia or hypersecretion status, and treatment for comorbidities should be considered a high priority in H pylori negative and drug negative peptic ulcer disease. 23 Further prospective studies are needed to clarify the underlining etiology, clinical characteristics, and management in this specific subgroup.
After adjusting all confounding factors using the multiple linear regression model, only H pylori infection and initial hemoglobin level were independent factors, and they were negatively associated to hospitalization days. In other words, subjects with H pylori infection and high initial hemoglobin level had a more favorable outcome. This result is consistent with previous findings. 24 Different etiologies of bleeding ulcers may result in a different profile of bleeding location. In this study, drug exposure was frequently associated with gastric ulcer bleeding with an OR of 2.34, and the OR of H pylori infection for combined gastric and duodenal ulcer bleeding was 2.64. These results confirmed similar findings from other studies. 25 They may provide information to endoscopists to assist in differentiating potential etiologies of peptic ulcer bleeding in individual patients.
In conclusion, in addition to H pylori infection, drug exposure, especially with NSAIDs, aspirin, and clopidogrel have become an important, emerging cause of peptic ulcer bleeding in Taiwan. A new and comprehensive preventive and therapeutic strategy for peptic ulcer bleeding is mandatory in the post-H pylori era.
